Daiwa Securities Group »

Zenas Biopharma shares owned by Daiwa Securities Group

Quarter-by-quarter ownership of Zenas Biopharma (ZBIO) shares owned by Daiwa Securities Group from 13F filings

Historical chart of Daiwa Securities Group investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by Daiwa Securities Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by Daiwa Securities Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.0k 179 33.52

More positions owned by Daiwa Securities Group

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Welltower Inc Com reit (WELL)
Palantir Technologies Cl A (PLTR)
Netflix (NFLX)
Crowdstrike Hldgs Cl A (CRWD)
Digital Realty Trust (DLR)
Prologis (PLD)
Alphabet Cap Stk Cl C Put Option (GOOG)
Crown Castle Intl (CCI)

View all positions for Daiwa Securities Group

Top funds holding Zenas Biopharma

Sr One Capital Management
FMR
Enavate Sciences GP
NEA Management Company
Federated Investors
Fairmount Funds Management
NVP Associates
BlackRock
Vanguard Group
Novo A/S
Polar Capital Holdings
Wellington Management Company
Vivo Capital
Arrowpoint Asset Management
EcoR1 Capital

View all funds holding Zenas Biopharma